1. Structure–activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities
- Author
-
Chang-Hsing Liang, Steven J. Sucheck, David Rabuka, San-Bao Hwang, Changyong Hu, Pamela Sears, Paulo W.M. Sgarbi, Youe-Kong Shue, Kenneth Marby, Alex Romero, Sulan Yao, Yoshitaka Ichikawa, Mayling L. Cheng, and Jonathan Duffield
- Subjects
Stereochemistry ,medicine.drug_class ,Clinical Biochemistry ,Antibiotics ,Drug Evaluation, Preclinical ,Pharmaceutical Science ,Microbial Sensitivity Tests ,medicine.disease_cause ,Biochemistry ,Mice ,Structure-Activity Relationship ,chemistry.chemical_compound ,Drug Discovery ,medicine ,Animals ,Humans ,Molecular Biology ,Neamine ,Antibacterial agent ,Mice, Inbred BALB C ,Chemistry ,Pseudomonas aeruginosa ,Organic Chemistry ,Aminoglycoside ,Anti-Bacterial Agents ,Aminoglycosides ,Staphylococcus aureus ,Molecular Medicine ,Female ,Pharmacophore ,Lead compound - Abstract
A library of 4,5- and 4,6-linked bivalent aminoglycoside (AMG) antibiotics consisting of neamine and nebramine pharmacophores have been synthesized. We probed the effect of the linker on antibiotic activity with a series of selected synthetic analogues with varied length and substituents. A number of compounds demonstrated in vitro activity against several bacterial strains and showed activity against drug resistant strains of Pseudomonas aeruginosa. Among the compounds prepared, analogues 12a–d were novel 4,6-linked AMGs containing the nebramine pharmacophore. In addition the lead compound OPT-11 possessed an ED50 of ⩽5 mg/kg in a Staphylococcus aureus ATCC 29213 mouse protection model.
- Published
- 2005